You are here: Industry Insights > Scott Gottlieb

News List

Head of National Cancer Institute Named Acting FDA Commissioner drugs
March 14, 2019
The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb, M.D., leaves the post next month.
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's steps on naming of biological medicines to balance competition and safety for patients receiving these products firstwordpharma
March 08, 2019
We're at a critical point for the future of biosimilars in the U.S. Millions of American patients stand to benefit from increased utilization of these lower-cost, high-quality products.
FDA Commissioner Scott Gottlieb to step down firstwordpharma
March 06, 2019
Health and Human Services Secretary (HHS) Alex Azar on Tuesday announced that FDA Commissioner Scott Gottlieb is resigning from his post and will step down next month.
BREAKING NEWS: FDA chief Scott Gottlieb steps down, leaving pet projects behind fiercepharma
March 06, 2019
Not quite two years into his stewardship of the FDA, Scott Gottlieb, M.D., is stepping down.
FDA recalls inspectors as shutdown drags on; Gottlieb calls PDUFA most 'vulnerable' fiercepharma
January 17, 2019
The FDA is recalling some furloughed employees to restart inspections despite a government shutdown. (FDA)
FDA Commissioner Scott Gottlieb blasts insulin pricing, unveils move to bolster biosimilar competition fiercepharma
December 14, 2018
As drug prices climb and the Trump administration works over ways to lower them, FDA commissioner Scott Gottlieb, M.D., has homed in on insulin prices as his agency's next target.
FDA is Advancing New Efforts to Address Drug Shortages fda
November 28, 2018
A key component of our public health mission is to help ensure Americans have access to safe and effective medicines.
Look who’s talking: FDA chief Scott Gottlieb churns out statements by the dozen fiercepharma
August 08, 2018
When the FDA talks, pharma listens. But what happens when the FDA talks way more than usual? We're finding out now, thanks to FDA Commissioner Scott Gottlieb and his torrent of public statements.
FDA chief Scott Gottlieb churns out statements by the dozen fiercepharma
August 07, 2018
When the FDA talks, pharma listens. But what happens when the FDA talks way more than usual? We're finding out now, thanks to FDA Commissioner Scott Gottlieb and his torrent of public statements.
Gottlieb looking to approve cancer treatments on earlier evidence pharmafile
December 04, 2017
US Food and Drug Administration Secretary Scott Gottlieb Speaks on 21st Century Heal before Energy and Business Council...

Previous page 1 2 Next page